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Previous studies have demonstrated impaired ventricular repolarization in patients with β-TM. However, the eﬀe c to fi r o n
overload with cardiac T2∗ magnetic resonance imaging (MRI) on cardiac repolarization remains unclear yet. We aimed to
examine relationship between repolarization parameters and iron loading using cardiac T2∗ MRI in asymptomatic β-TM patients.
Twenty-two β-TM patients and 22 age- and gender-matched healthy controls were enrolled to the study. From the 12-lead
surface electrocardiography, regional and transmyocardial repolarization parameters were evaluated manually by two experienced
cardiologists. All patients were also undergone MRI for cardiac T2∗ evaluation. Cardiac T2∗ score <20msec was considered as
iron overload status. Of the QT parameters, QT duration, corrected QT interval, and QT peak duration were signiﬁcantly longer
in the β-TM group compared to the healthy controls. Tp − Te and Tp − Te dispersions were also signiﬁcantly prolonged in β-TM
group compared to healthy controls. (Tp − Te)/QT was similar between groups. There was no correlation between repolarization
parameters and cardiac T2∗ MRI values. In conclusion, although repolarization parameters were prolonged in asymptomatic
β-TM patients compared with control, we could not ﬁnd any relation between ECG ﬁndings and cardiac iron load.
1.Introduction
Beta-thalassemia major (β-TM) is a hereditary hemogolino-
pathy caused by impaired synthesis of β-globin chain and
requires frequent blood transfusions [1]. In a consequence of
transfusions, iron overload may develop. Deposition of iron
in the heart may occur and cause severe cardiac complica-
tions such as heart failure and malignant arrhythmias [2].
The incidence of iron overload cardiomyopathy ranges from
11.4 to 15.1% in β-TM patients [3, 4] .D e s p i t ea d v a n c e si n
chelating therapy, cardiovascular complications still remain
main cause of mortality and morbidity in patients with β-
TM [4].
Conventional QT parameters and transmyocardial repo-
larization parameters including Tpeak − Tend interval
(Tp −Te), dispersion ((Tp − Te)d), and (Tp − Te)/QT
ratio have been used to predict cardiac arrhythmias in a
numberofclinicalconditionssuchasBrugadasyndromeand
hypertrophic cardiomyopathy [5–7]. There are controversial
results regarding conventional QT parameters in patients
with β-TM. Although QT prolongation was demonstrated
in patients with β-TM [8–10], there are studies with no
statistical diﬀerence in the recent group [11, 12]. Chronic
iron overload can lead to variety of arrhythmias including
atrioventricular block, conduction defects, bradyarrhyth-
mias, tachyarrhythmias, and sudden cardiac death (SCD) in
patients with iron-overload cardiomyopathy [13–16]. Ulger
et al. [9] investigated the role of ferritin on QT parameters
in patients with β-TM and found no correlation of QT2 Advances in Hematology
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Figure 1: Measurement of P wave parameters on 12-lead surface ECG.
parameters with both serum ferritin levels and liver iron
concentration. Interestingly, two experimental models have
found that iron does not cause arrhythmias in guinea pig
modelandgerbil[17,18].CardiacT2∗ MRIismoresensitive
and speciﬁc method to predict iron loading than plasma fer-
ritin levels and liver T2∗ measurement [19]. Cardiac T2∗
MRI identiﬁes patients at high risk of heart failure and
arrhythmia from myocardial siderosis in β-TM [20]. How-
ever, the relation of these repolarization parameters with car-
diac T2∗ MRI value was not yet studied. The relationship
between iron overload and electrocardiographic repolariza-
tion abnormalities remains controversial. Therefore, we
aimed to investigate regional and transmyocardial repolari-
zationparametersinβ-TMpatientsandexaminetherelation
of these repolarization parameters with cardiac T2∗ MRI
value.
2.MaterialandMethods
2.1. Study Population. This is a cross-sectional case control
study which was conducted at the Hematology department,
Selcuk University, in Konya, Turkey. Twenty-two (14 men,
mean age 26 ± 9 years) with diagnosis of β-TM and 22
age- and gender-matched healthy subjects were prospectively
enrolled to the study. Included patients gave their verbal and
written consent for participation in the study. The study
was approved by the local ethical committee. The diagno-
sisofTMwasmadeonhemogram,bloodsmear,hemoglobin
electrophoresis, and clinical evaluation. The patients had
been regularly transfused (every 3-4 weeks), and every-
one received chronic chelation therapy (deferoxamine or
deferiprone). Exclusion criteria were diabetes mellitus, his-
tory of coronary artery disease, congestive heart failure, con-
genital or acquired arrhythmia syndromes, use of drugs
that lengthen the QT interval, current AF, bundle branch
block, atrioventricular blocks, and unmeasurable T waves
(<0.15mV) on surface ECG.
2.2. ECG Recording and Analyses. Surface 12-lead standard
ECGs were recorded from each patient with a 50mm/s paper
speed at 10mm/mV amplitude. Timing of electrocardiogra-
phic measurements was adjusted to the last blood transfu-
sion, so ECG was performed at least two weeks later after
bloodtransfusion.TheECGswerescannedata600dpiresol-
ution and analyzed manually by two experts who were
blinded to the clinical status of the study population.
Three consecutive ECG complexes were analyzed and given
averaged measures for each lead.
The QT intervals were measured from the onset of the
ﬁrst deﬂection of the QRS complex to the end of T wave in
all12leads.IftheTwavewasﬂatortheendoftheTwavewas
diﬃcult to deﬁne, or if the T wave amplitude was <0.15mV,
the lead was excluded from measurement. The end of the QT
interval was deﬁned as the intersection of the terminal part
of the T wave and the isoelectric line. If a U wave interrupted
the T wave before it returned to baseline, the end of the QT
interval was deﬁned as the nadir between T and U waves.
Corrected QT interval (cQT) was calculated using
Bazett’s formula (cQT = QT/
√
R − R interval). cQT disper-
sion(cQTd)wasdeﬁnedasthediﬀerencebetweenmaximum
cQT and minimum cQT.
Tp − Te interval was deﬁned as the interval between QT
a n dQ Tp e a k( Tp −Te = QT−QTp). The diﬀerence between
maximumTp−Te andminimumTp−Te wasdeﬁnedasTp−
Te dispersion (Figure 1). The ratio of Tp −Te to QT duration
(Tp − Te/QT) was also calculated. Intra- and interobserver
variablities for Tp − Te were determined of 6.7% and 8.3%,
respectively.
2.3. Cardiac Magnetic Imaging. Iron loading in the heart was
evaluated with MRI T2∗.M Ri m a g e sw e r ea c q u i r e df o ra l l
patients with a single imager equipped with a 1.5T magnet
(SiemensSymphonyErlangen,Germany).Bodyphasedarray
coil to image a single 10mm midventricular short axis slice
ateight echoes times (ranging from3ms to 21ms, increment
2.6ms) with ECG gating and breath hold was also utilized.
A gradient-echo sequence was used (ﬂip angle 35, matrix
128×256). Double inversion recovery pulses were applied to
suppress the blood signal and data was acquired every other
cardiac cycle. The monoexponential decay model and the
nonlinear curve ﬁtting algorithm were used to ﬁt the curve
to obtain T2 measurement. We used CMR Tools software
(http://www.cmrtools.com/) for quantiﬁcation.
2.4. Statistical Analysis. The statistical analysis was per-
formed with the help of the Statistical Package for Social
Sciences (SPSS for Windows) software (version 15.0) (SPSS
Inc., Chicago, IL). The relation between the categorical vari-
ables was determined by the chi-square test. The distribution
of the variables was analyzed with the Kolmogorov-Smirnow
test. The Mann-Whitney U test was used for nonparametric
comparison of two groups. A Spearman correlation test wasAdvances in Hematology 3
Table 1: Clinical, demographic, and laboratory characteristics of
the study population.
β-TM (n = 22) Control (n = 22) P value
Age (years) 26 ±92 8 ±70 . 4 7
Gender
Female/male (n) 14/8 16/6 0.33
BMI (kg/m2)2 3 ±2.02 4 ±1.60 . 4 4
SBP (mmHg) 122 ±14 121 ±16 0.36
DBP (mmHg) 81 ±67 0 ±70 . 2 2
Heart rate (bpm) 85 ±87 6 ±7 0.004
Hemoglobin (g/dL) 10.4 ±1.31 3 .3 ±1.2 0.001
Hematocrit (%) 34.3 ±6.64 4 .2 ±2.6 0.001
Cardiac T2∗ MRI (ms) 23 ±16 — —
Chelation therapy (%) 100 — —
β-TM: β-thalassemia major; BMI: body-mass index; SBP: systolic blood
pressure; DBP: diastolic blood pressure; MRI: magnetic resonance imaging.
P = 0.002
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Figure 2: A comparison of QT, QTc, and QTp in patients with β-
TM and healthy controls.
used to assess linear association. The data were expressed as
mean ± standard or median (inter quartile range) deviation
according to the distribution properties, and P value under
0.05 was considered statistically signiﬁcant.
3. Results
Table 1 summarizes the clinical, laboratory, and echocar-
diographic characteristics of the study population. β-TM
patients were not diﬀerent from the control group in age,
gender, body-mass index, or blood pressure levels. The mean
cardiac T2∗ value of patients with β-TM was 21.7 ± 9.0ms.
Hemoglobin (Hb) and hematocrit (Hct) levels were signi-
ﬁcantly lower in β-TM group than in the control group
(Table 1). Heart rate was signiﬁcantly increased in β-TM
patients than controls (85 ± 8bpm versus 78 ± 7bpm,
P = 0.02
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Figure 3: A comparison of Tp −Te and (Tp −Te)d in patients with
β-TM and healthy controls.
Table 2: Electrocardiographic parameters of the β-TM group and
controls.
Controls (n = 22) β-TM (n = 22) P value
QT (ms) 348 ±26 374 ±25 0.002
QTd (ms) 40 ±10 40 ±16 0.87
QTp (ms) 265 ±27 285 ±22 0.009
(QTp)d (ms) 32 ±15 31 ±9.00 . 7 7
QTc (ms) 396 ±32 445 ±26 <0.001
cQTd (ms) 46 ±12 48 ±18 0.74
Tp −Te (ms) 79 ±12 89 ±15 0.02
(Tp −Te)d (ms) 39 ±11 48 ±17 0.03
(Tp −Te)/QT 0.22 ±0.03 0.23 ±0.03 0.32
QRS duration (ms) 88 ±14 93 ±12 0.28
Heart rate (bpm) 78 ±78 5 ±8 0.004
β-TM: β-thalassemia major; QTd: QT dispersion; QTp: peak QT; (QTp)d:
peak QT dispersion; QTc: corrected QT; cQTd: corrected QT dispersion;
Tp − Te:d i ﬀerence between T-peak and T-end; (Tp − Te)d: Tp − Te
dispersion.
P = 0.004) (Table 1). Mean cardiac T2∗ MRI value was 23 ±
16msec.
Twelve-lead surface ECG analysis of repolarization
parameters is listed in Table 2. With regard to regional QT
parameters, compared with healthy controls, β-TM patients
presented with increased QT duration (374 ± 25ms versus
348±26ms,P = 0.002,resp.),QTc(445±26msversus396±
32ms, P<0.001, resp.), and peak QT duration (285 ±22ms
versus 265 ± 27ms, P = 0.009, resp.) (Figure 2). QTd and
cQTd were comparable in two groups (P = 0.87 and P =
0.74, resp.). Tp −Te and (Tp −Te)d were signiﬁcantly higher
in β-TM group than that in controls (P = 0.02 and P =
0.03, resp.) (Figure 3). No statistically signiﬁcant diﬀerence4 Advances in Hematology
Table 3: Electrocardiographic ﬁndings of patients with β-TM
according to cardiac T2∗ scores.
ECG parameters T2∗ < 20msec
n = 12
T2∗ ≥ 20msec
n = 10 P value
QT (msec) 378 ±28 387 ±24 0.62
QTc (msec) 468 ±35 478 ±38 0.48
QTp (msec) 293 ±25 291 ±25 0.84
QTd (msec) 38 ±11 40 ±17 0.46
cQTd (msec) 48 ±15 51 ±17 0.59
Tp −Te (msec) 85 ±15 87 ±13 0.57
(Tp −Te)d (msec) 47 ±17 47 ±16 0.94
Tp −Te/QT ratio 0.22 ±0.03 0.24 ±0.03 0.12
QRS duration (msec) 101 ±19 99 ±15 0.86
HR (bpm) 89 ±11 92 ±17 0.63
Table 4: Correlation and statistical signiﬁcance of the ECG para-
meters to cardiac T2∗ values.
r P
QT −0.17 0.46
QTc −0.08 0.73
QTp −0.29 0.18
QTd −0.04 0.87
cQTd −0.02 0.93
Tp −Te −0.36 0.09
(Tp − Te)d −0.04 0.86
Tp −Te/QT 0.31 0.14
was found in Tp − Te/QT ratio (P = 0.32) and T-wave
amplitude (P = 0.39). Heart rate was signiﬁcantly increased
in patient group compared to control group (85 ± 8bpm
versus 78 ±7bpm,P = 0.004, resp.) (Table 2).
ECG ﬁndings were similar in those patients with cardiac
T2∗ < 20 msec and those with cardiac T2∗ ≥ 20 msec
(Table 3). Both conventional QT and transmyocardial repo-
larization parameters did not show signiﬁcant correlation
with cardiac T2∗ MRI value (Table 4).
4. Discussion
The present study demonstrated that repolarization parame-
ters including QT, QTc, QTp, Tp − Te,a n d( Tp − Te)d were
signiﬁcantly prolonged in patients with β-TM compared to
healthy subjects. Neither conventional QT parameters nor
transmyocardial repolarization parameters were correlated
with cardiac T2∗ MRI values. To the best of our knowledge,
the present study is a ﬁrst time study, where the relation
between cardiac T2∗ MRI values and transmyocardial repo-
larization parameters was investigated.
Cardiac complications, including arrhythmias, are
among the leading causes of morbidity and mortality of
transfusion-dependent, iron-overloaded β-TM patients [3].
Patients with chronic iron overload may develop a cardio-
myopathy manifested by ventricular arrhythmias and heart
failure [16]. Early detection of cardiac arrhythmias among
transfusion-dependent β-TM patients is indicated for
reduction of morbidity and mortality. The toxicity of iron
was attributed to the following mechanisms: (a) excessive
intracellular iron interferes with electrical function of the
heart [21], (b) catalyze the generation of free radicals [22],
and(c)causeselectivedysfunctionofNa+ channels[23].Fur-
thermore, iron overload may lead to apoptosis and ﬁbrosis
[2].
Evaluation of conventional QT parameters was previ-
ously performed in β-TM patients. The results of these
studies were conﬂicting. Some of them found prolonged QT,
QTc, QTd, and cQTd in β-TMpatientscomparedtocontrols
[8–10]. In the contrary, there are two controversial studies
which found conventional QT and dispersion parameters of
no statistical diﬀerence between β-TM patients and controls
[11, 12]. In our study, QT, QTc, and QTp were prolonged in
patients with β-TM.
The relationship between QT parameters and iron over-
load measured by serum ferritin level was investigated previ-
ously. Ulger et al. [9] found no correlation of QT parameters
(QT, QTc, QTd, and cQTd) with both serum ferritin level
and liver iron concentration in β-TM patients. There is only
a study where Magri et al. [12] demonstrated that cardiac
T2∗ MRI was signiﬁcantly correlated with QT variability
index but not with QTc. We also found that none of the
conventional QT measurements were correlated with cardiac
T2∗ MRI. We speculated that QT variability index may be
more reliable to predict iron overload arrhythmias than con-
ventional QT parameters. However, the measurement of QT
variability index is very complex and requires more time
records, additional software program, and complex formula.
Therefore, clinic implication of QT variability parameters is
limited.
Regardingtransmyocardialrepolarization,therearethree
layers in the myocardium: the endocardial, the M-cell, and
the epicardial layer. The myocardial layers are at diﬀer-
ent repolarization phases creating transmyocardial nonho-
mogeneities, which become substrates for reentry causing
malignant arrhythmias [24]. These transmyocardial nonho-
mogeneities are determined by the ECG parameters Tp −
Te,( Tp − Te)d,a n d( Tp − Te)/QT ratio. Therefore we
think that myocardial iron overload may contribute to creat-
ingtransmyocardialnonhomogeneityandtheseECGparam-
eters may better demonstrate the relation between iron
overload and repolarization parameters than conventional
QT parameters. However, the data in Tp − Te are very scarce
in β-TM patients. There is only a study where Kocharian
et al. [8] demonstrated prolonged Tp − Te and (Tp − Te)d
in patients with β-TM. Nevertheless, they did not investi-
gate (Tp − Te)/QT ratio. We also found higher transmy-
ocardial repolarization parameters except for (Tp − Te)/QT
ratio in β-TM patients compared to the healthy subjects. In
contrast to conventional QT parameters, there is no study
investigating the relation between transmyocardial repolari-
zation parameters and both ferritin levels and cardiac iron
load. For the ﬁrst time, we investigated the relation of trans-
myocardial repolarization parameters with cardiac T2∗ val-
ues. In our study, we found no diﬀerence in transmyocardial
repolarization parameters in patients with T2∗ < 20 msecAdvances in Hematology 5
and those with T2∗ ≥ 20msec. In addition, there was no
linear relation between transmyocardial repolarization para-
meters and cardiac T2∗ values. These results support the
theory that ﬁbrosis as a cause of iron overload may be more
deleterious than iron itself. Iron alone is not suﬃcient to
causearrhythmiaandothercomorbidconditionscancontri-
bute to arrhythmias. This issue was observed in nonhuman
models [17, 18]. In addition, cardiac arrhythmias were not
solely related to iron overload in patients with hemochro-
matosis [25]. Taken together, these data suggest that iron
alone may be necessary but insuﬃcient to cause cardiac
arrhythmia in iron-overload conditions.
5. Limitations
A few limitations deserve mention: (a) this study is a cross-
sectional study with small sample size and large prospective
randomized studies are needed to clarify the relationship
between the both impaired regional and transmyocardial
repolarization parameters and subsequent cardiac events in
β-TM patients, (b) we did not perform cardiac MRI in con-
trol group because of cost. In addition, because of contro-
versial results in the literature, we aimed to evaluate whether
repolarization parameters are impaired in patients with β-
TM or not, (c) β-TM patients were under chelation ther-
apy and this type of therapy may blind results of the study.
Therefore our results may not be applicable to patients not
undergoing this kind of therapy, (d) because of speculations
that ﬁbrosis as a cause of iron load may impair repolariza-
tion parameters, we think that investigation of noninvasive
markers of ﬁbrosis, such as metalloproteinase, procollagen
type I, and procollagen type III needs to be investigated in
future.
6. Conclusion
The present study demonstrated that repolarization parame-
ters are impaired in asymptomatic β-TM patients and it was
unrelatedwithcardiacT2∗ MRIvalues.Thusitneedstowell-
designed randomized investigations in this area.
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